<DOC>
	<DOCNO>NCT02199678</DOCNO>
	<brief_summary>This Phase 2 , randomize , multicenter , parallel group , double-blind , dose-ranging , placebo-controlled evaluation analgesic efficacy , safety pharmacokinetics ketamine sublingual wafer adult subject experience post operative pain undergoing third molar extraction .</brief_summary>
	<brief_title>A Study Assess Analgesic Properties Sublingual Wafer Formulation Ketamine Following Third Molar Extraction</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>18 38 year age Scheduled undergo two ipsilateral third molar extraction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>